SCHEMBL25911341

SCHEMBL25911341

NCCOC1CCOCC1

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 1/20 0.41
DCPS Q96C86 1/20 0.33
AOC2 O75106 1/20 0.31
NPC1 O15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13162816 0.82
SCHEMBL11780411 0.82 NPC1 (0.36) NPC1
SCHEMBL20713619 0.80
Hydrochloric Acid SCHEMBL2770966 0.79
SCHEMBL18824825 0.77
SCHEMBL1860292 0.77
SCHEMBL24272656 0.76 NPC1 (0.30) NPC1
SCHEMBL18239672 0.76 SPHK1 (0.37) SPHK1NPC1
SCHEMBL666787 0.76 SPHK1 (0.37) SPHK1NPC1
SCHEMBL578882 0.76 SPHK1 (0.41) SPHK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230226186-A1 RAS INHIBITORS WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230226186-A1 RAS INHIBITORS KRAS, NRAS, HRAS SPHK1 3694/4885DCPS 3110/4885AOC2 4551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.